Impact of concomitant medication on recurrence, survival and tolerability of chemotherapy in early colon cancer patients - A post-hoc analysis of the PETACC 8 trial.

Date publication

juillet 2025

Journal

European journal of cancer (Oxford, England : 1990)

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BOUCHE Olivier , Pr LEPAGE Côme

Tous les auteurs :
Bergen ES, Canton C, Boulin M, Le Malicot K, Bennouna J, Gonzalez D, Mineur L, Bouche O, Lepage C, Taieb J

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/40680466

Résumé

Only few information is available about the impact of concomitant medication (CM) and comorbidities on the outcome of cancer patients and the tolerability of chemotherapy.

Mots clés

ATC classification, Adjuvant chemotherapy, Colon cancer, Comorbidities, Side effects, Survival, concomitant medication, toxicity

Référence

Eur J Cancer. 2025 07 12;227:115643